Literature DB >> 8981391

Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability?

E Bartlett1, A Hallin, B Chapman, B Angrist.   

Abstract

Patients in inpatient rehabilitation for uncomplicated cocaine dependence were asked whether, compared with the time of their first regular use, they could now identify changes in the effects of similar doses of cocaine. We asked about a spectrum of cocaine effects "then" and "now" and whether the same amount of drug caused effects to occur to about the same degree, less intensely (tolerance), or more intensely (sensitization). Nearly half our sample developed predominantly paranoid psychoses in the context of cocaine use. Sensitization was consistently linked only to psychosis-related cocaine effects. It has been proposed that mesolimbic dopaminergic sensitization might contribute to addiction severity. A preliminary followup of patients who were sensitized or nonsensitized to psychosis development suggests that rehospitalization for treatment of addiction may be more frequent in the sensitized group.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8981391     DOI: 10.1016/S0893-133X(96)00164-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  24 in total

1.  Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  J Neurosci       Date:  2006-08-02       Impact factor: 6.167

Review 2.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

3.  Adolescent cannabis use increases risk for cocaine-induced paranoia.

Authors:  Rasmon Kalayasiri; Joel Gelernter; Lindsay Farrer; Roger Weiss; Kathleen Brady; Ralitza Gueorguieva; Henry R Kranzler; Robert T Malison
Journal:  Drug Alcohol Depend       Date:  2009-11-26       Impact factor: 4.492

4.  mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization.

Authors:  Xine Shen; Chris Purser; Lu-Tai Tien; Chi-Tso Chiu; Ian A Paul; Rodney Baker; Horace H Loh; Ing K Ho; Tangeng Ma
Journal:  J Neurosci Res       Date:  2010-08-01       Impact factor: 4.164

Review 5.  Cocaine sensitization and dopamine mediation of cue effects in rodents, monkeys, and humans: areas of agreement, disagreement, and implications for addiction.

Authors:  Charles W Bradberry
Journal:  Psychopharmacology (Berl)       Date:  2006-10-10       Impact factor: 4.530

6.  Dose-dependent changes in the locomotor responses to methamphetamine in BALB/c mice: low doses induce hypolocomotion.

Authors:  Rana A K Singh; Therese A Kosten; Berma M Kinsey; Xiaoyun Shen; Angel Y Lopez; Thomas R Kosten; Frank M Orson
Journal:  Pharmacol Biochem Behav       Date:  2012-08-28       Impact factor: 3.533

Review 7.  Cued for risk: Evidence for an incentive sensitization framework to explain the interplay between stress and anxiety, substance abuse, and reward uncertainty in disordered gambling behavior.

Authors:  Samantha N Hellberg; Trinity I Russell; Mike J F Robinson
Journal:  Cogn Affect Behav Neurosci       Date:  2019-06       Impact factor: 3.282

Review 8.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

9.  Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90).

Authors:  Icro Maremmani; Pier Paolo Pani; Matteo Pacini; Jacopo V Bizzarri; Emanuela Trogu; Angelo Gi Maremmani; Gilberto Gerra; Giulio Perugi; Liliana Dell'Osso
Journal:  Ann Gen Psychiatry       Date:  2010-04-13       Impact factor: 3.455

Review 10.  A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia.

Authors:  Martin Sarter; Vicente Martinez; Rouba Kozak
Journal:  Psychopharmacology (Berl)       Date:  2008-07-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.